BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 19610612)

  • 21. Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer.
    DeSouza LV; Romaschin AD; Colgan TJ; Siu KW
    Anal Chem; 2009 May; 81(9):3462-70. PubMed ID: 19323455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of the SILAC (stable isotope labelling with amino acids in cell culture) technique in quantitative comparisons for tissue proteome expression.
    Xu Y; Liang S; Shen G; Xu X; Liu Q; Xu Z; Gong F; Tang M; Wei Y
    Biotechnol Appl Biochem; 2009 Jul; 54(1):11-20. PubMed ID: 19250064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma.
    Okamura N; Masuda T; Gotoh A; Shirakawa T; Terao S; Kaneko N; Suganuma K; Watanabe M; Matsubara T; Seto R; Matsumoto J; Kawakami M; Yamamori M; Nakamura T; Yagami T; Sakaeda T; Fujisawa M; Nishimura O; Okumura K
    Proteomics; 2008 Aug; 8(15):3194-203. PubMed ID: 18615424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma.
    Ohshiro K; Rosenthal DI; Koomen JM; Streckfus CF; Chambers M; Kobayashi R; El-Naggar AK
    Int J Oncol; 2007 Mar; 30(3):743-9. PubMed ID: 17273777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candidate biomarkers in renal cell carcinoma.
    Seliger B; Dressler SP; Lichtenfels R; Kellner R
    Proteomics; 2007 Dec; 7(24):4601-12. PubMed ID: 18072195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation.
    Liang S; Xu Y; Shen G; Liu Q; Zhao X; Xu Z; Xie X; Gong F; Li R; Wei Y
    Electrophoresis; 2009 Dec; 30(23):4152-62. PubMed ID: 19960480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
    Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
    Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential gene expression identifies subgroups of renal cell carcinoma.
    Skubitz KM; Zimmermann W; Kammerer R; Pambuccian S; Skubitz AP
    J Lab Clin Med; 2006 May; 147(5):250-67. PubMed ID: 16697773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation.
    Sarvaiya HA; Yoon JH; Lazar IM
    Rapid Commun Mass Spectrom; 2006; 20(20):3039-55. PubMed ID: 16986208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.
    Masui O; White NM; DeSouza LV; Krakovska O; Matta A; Metias S; Khalil B; Romaschin AD; Honey RJ; Stewart R; Pace K; Bjarnason GA; Siu KW; Yousef GM
    Mol Cell Proteomics; 2013 Jan; 12(1):132-44. PubMed ID: 23082029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
    Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
    J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein/RNA coextraction and small two-dimensional polyacrylamide gel electrophoresis for proteomic/gene expression analysis of renal cancer biopsies.
    Barbero G; Carta F; Giribaldi G; Mandili G; Crobu S; Ceruti C; Fontana D; Destefanis P; Turrini F
    Anal Biochem; 2006 Feb; 349(1):62-71. PubMed ID: 16307718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aberrant methylation of tumor suppressor genes in renal cell carcinoma].
    Zhang Q; Jin J; Tao Q
    Ai Zheng; 2007 Nov; 26(11):1276-80. PubMed ID: 17991333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma.
    Craven RA; Stanley AJ; Hanrahan S; Dods J; Unwin R; Totty N; Harnden P; Eardley I; Selby PJ; Banks RE
    Proteomics; 2006 May; 6(9):2853-64. PubMed ID: 16596713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
    Yang J; Liu P; Tian M; Li Y; Chen W; Li X
    Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry.
    Garbis SD; Tyritzis SI; Roumeliotis T; Zerefos P; Giannopoulou EG; Vlahou A; Kossida S; Diaz J; Vourekas S; Tamvakopoulos C; Pavlakis K; Sanoudou D; Constantinides CA
    J Proteome Res; 2008 Aug; 7(8):3146-58. PubMed ID: 18553995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of S100 protein in renal cell carcinoma and its relation with P53].
    Yang JF; Zhang XY; Qi F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):301-4. PubMed ID: 16136965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.
    Tyan YC; Yang MH; Chen SC; Jong SB; Chen WC; Yang YH; Chung TW; Liao PC
    Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2851-62. PubMed ID: 21913264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical identification of differentially labeled peptides from liquid chromatography tandem mass spectrometry.
    Cho H; Smalley DM; Theodorescu D; Ley K; Lee JK
    Proteomics; 2007 Oct; 7(20):3681-92. PubMed ID: 17879999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.